The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.
There is a good chance I will look to move my proposed entry level closer to market this week, but I still maintain that while momentum is extremely strong, signs on the hourly chart suggest the stock could pull back a touch.
It is also worth bearing in mind that US pharma giant Baxter reports on Thursday and it is a key rival of CSL, so traders will be keen to look out for signs that CSL has picked up market share.